Takeda Pharmaceutical
TAK
#483
Rank
$48.35 B
Marketcap
$14.53
Share price
1.39%
Change (1 day)
11.94%
Change (1 year)

Takeda Pharmaceutical (TAK) Fails to deliver data

Key failure to deliver metrics for Takeda Pharmaceutical:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Takeda Pharmaceutical (TAK) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Takeda Pharmaceutical (TAK) - since 2013

Volume in USD (price x number of shares), data since 2013

Takeda Pharmaceutical (TAK) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025$75.96 M115.55%
2024$35.24 M-70.76%
2023$0.12 B113.2%
2022$56.53 M-68.82%
2021$0.18 B692.67%
2020$22.87 M-91.87%
2019$0.28 B-34.7%
2018$0.43 B582.42%
2017$63.16 M35.85%
2016$46.49 M196.68%
2015$15.67 M54.27%
2014$10.15 M537.98%
2013$1.59 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Johnson & Johnson
JNJ
$57.52 M$0.10 B๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
$9.04 M$67.5 M๐Ÿ‡ซ๐Ÿ‡ท France
Pfizer
PFE
$29.26 M$0.10 B๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$19.76 M$75.6 M๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Seagen
SGEN
N/A$3.02 M๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
$1.04 M$28.57 M๐Ÿ‡ฎ๐Ÿ‡ณ India
Amgen
AMGN
$21.81 M$0.20 B๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
$61.56 M$0.39 B๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
$17.08 M$0.16 B๐Ÿ‡บ๐Ÿ‡ธ USA